Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
4.050
-0.170 (-4.03%)
Feb 21, 2025, 4:00 PM EST - Market closed
Mural Oncology Employees
Mural Oncology had 117 employees as of December 31, 2023.
Employees
117
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,314,325
Market Cap
69.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 117 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MURA News
- 4 days ago - Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 6 weeks ago - Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts - GlobeNewsWire
- 2 months ago - Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer - GlobeNewsWire
- 3 months ago - Mural Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - GlobeNewsWire
- 4 months ago - Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - GlobeNewsWire
- 5 months ago - Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi - GlobeNewsWire